Zosano Pharma Current Cash

Zosano Pharma (ZSAN) currently reports a current cash of $14M as of March 2022. That compares with $27M in the prior-year period — down 49.7% year over year. Use the charts on this page to explore Zosano Pharma's current cash history and peer comparisons.

Zosano Pharma's current cash decreased from $27M to $14M — a 49.7% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zosano Pharma reported $14M in current cash as of March 2022. That compares with $27M in the prior-year period — down 49.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zosano Pharma, and consider following ZSAN for alerts when major investors trade the stock.

Zosano Pharma is classified in the Healthcare sector. On current cash, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZSAN with unrelated industries.